Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 1/20 | 0.54 |
| ▸ | CA1 | P00915 | 1/20 | 0.50 |
| ▸ | CA2 | P00918 | 1/20 | 0.50 |
| ▸ | CA4 | P22748 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 2/20 | 0.33 |
| ▸ | HRH2 | P25021 | 1/20 | 0.33 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.33 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | NOS3 | P29474 | 1/20 | 0.31 |
| ▸ | NOS1 | P29475 | 1/20 | 0.31 |
| ▸ | NOS2 | P35228 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21114252 | 1.00 | KMT2A (0.54) | KMT2ACA1CA2CA4GAA | |
| SCHEMBL21114295 | 1.00 | KMT2A (0.54) | KMT2ACA1CA2CA4GAA | |
| SCHEMBL21114291 | 1.00 | KMT2A (0.54) | KMT2ACA1CA2CA4GAA | |
| SCHEMBL1532392 | 1.00 | KMT2A (0.54) | KMT2ACA1CA2CA4GAA | |
| SCHEMBL258383 | 1.00 | — | — | |
| SCHEMBL4468 | 0.97 | — | — | |
| SCHEMBL5278 | 0.88 | — | — | |
| SCHEMBL7557757 | 0.76 | KMT2A (0.52) | KMT2ACA1CA2CA4GAA | |
| SCHEMBL1051638 | 0.76 | KMT2A (0.52) | KMT2ACA1CA2CA4GAA | |
| SCHEMBL1051636 | 0.76 | KMT2A (0.52) | KMT2ACA1CA2CA4GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109790284-B | Polyphenol compound and process for producing the same | 三菱化学株式会社 | 2021-09-21 | — | — | CN | disclosed |
| US-10851039-B2 | Polyhydric phenol compound and method of producing same | MITSUBISHI CHEMICAL CORPORATION (JP) | 2020-12-01 | — | — | US | disclosed |
| US-10793499-B2 | — | — | 2020-10-06 | — | — | US | disclosed |
| EP-3514193-A1 | POLYVALENT PHENOL COMPOUND AND METHOD OF PRODUCING SAME | Mitsubishi Chemical Corporation (JP) | 2019-07-24 | — | — | EP | disclosed |
| US-20190210947-A1 | POLYHYDRIC PHENOL COMPOUND AND METHOD OF PRODUCING SAME | MITSUBISHI CHEMICAL CORPORATION (JP) | 2019-07-11 | — | — | US | disclosed |
| EP-0177807-A2 | Hexanoates, process for their preparation and perfumes and/or flavouring agents having a content of such compounds | L. GIVAUDAN & CIE Société Anonyme (CH) | 1986-04-16 | — | — | EP | disclosed |
| EP-0137419-A2 | Perfume compositions containing benzyl ethers | L. GIVAUDAN & CIE Société Anonyme (CH) | 1985-04-17 | — | — | EP | disclosed |
| EP-0011877-A1 | Carane derivatives, process for their preparation, their use as perfumes, and perfume compositions containing them | L. Givaudan & Cie Société Anonyme (CH) | 1980-06-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190210947-A1 | POLYHYDRIC PHENOL COMPOUND AND METHOD OF PRODUCING SAME | RB1, FHIT, H1-4 | KMT2A 1078/4885CA1 1421/4885CA2 704/4885 |
| US-10851039-B2 | Polyhydric phenol compound and method of producing same | RB1, FHIT, H1-4 | KMT2A 1078/4885CA1 1421/4885CA2 704/4885 |
| US-10793499-B2 | — | RB1, H1-4, TPD52L2 | KMT2A 1044/4885CA1 2157/4885CA2 796/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.